Berlin-Buch health location in the northeast of Berlin

Similar documents
The Power to Cure: Therapeutic Innovation in Academia

How Targets Are Chosen. Chris Wayman 12 th April 2012

Cluster Healthcare Industries Berlin-Brandenburg. HealthCapital

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms

ATIP Avenir Program 2018 Young group leader

Antibody Discovery at Evotec

Welcome to 5 th Munich Biomarker Conference

THE INDUSTRY S FUTURE LABORATORY Information for Visitors

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview

- OMICS IN PERSONALISED MEDICINE

Integration of FDSS7000 into a modular robotic system for Open Innovation drug discovery

Advancing Life Sciences

From Bench To Clinic : a personal journey Career Research Advancement Focused Training

TRAIN the Translational Alliance in Lower Saxony. Prof. Dr. Ulrich Kalinke Executive Director TWINCORE Head of TRAIN office

Centre for Personalised Medicine in Tübingen - developing tailor-made treatments for patients

Introduction to Drug Design and Discovery

Clusters as a tool for Innovation at the University of Debrecen. Prof. Dr. József Tőzsér Deputy Rector, University of Debrecen

CIEE Global Institute Berlin

Innovative Medicines Initiative

Biomarker discovery. Enabling pharmaceutical and biotech partners to discover relevant biomarkers in diseases of interest

A GATEWAY TO ACADEMIC EXCELLENCE FOR BIOTECH AND PHARMA

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University

A gateway to academic excellence for Biotech and Pharma

UMBC-Shady Grove: Translational Life Science Technology (TLST)

Career Growth Areas in Physiology / Pharmacology

MASTER S DEGREE IN BIOTECHNOLOGY AND MEDICAL BIOLOGY. Faculty of Medicine and Surgery

PATIENT STRATIFICATION. 15 year A N N I V E R S A R Y. The Life Sciences Knowledge Management Company

The Integrated Biomedical Sciences Graduate Program

Current Research. Examples of current research projects:

SMEs in IMI2 Calls for Proposals

Our website:

L A B O R M A R K E T B R I E F I N G S S E R I E S

Our job today Enlist you to help us cross the Translational Divide between the lab bench and the patient s bedside Demonstrate that this will

Pioneering Clinical Omics

Bavarian Biotech Inside Shaping the Future of Medicine.

A Biomedical Research and Biotechnology Center to Promote the Growth of World-Class Biotech Industry in Southern Italy

International Conference on Engineering Technology & Applied Sciences Theme: Discovery, Invention & Innovation of Technology

Saudi Pharmacist Licensure Examination (SPLE)

UNLEASH THE POWER OF PRECISION MEDICINE

Course Agenda. Day One

Drug target identification. Enabling our pharmaceutical and biotech partners to effectively discover proteins or genes as novel targets

Program overview. SciLifeLab - a short introduction. Advanced Light Microscopy. Affinity Proteomics. Bioinformatics.

Marineinspired Oncology

Northwestern s Shared and Core Facilities

FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du)

Fast Track Drug Development The Clinical (Caleidoscopic) Perspective

COURSES IN BIOLOGICAL SCIENCE. Undergraduate Courses Postgraduate Courses

Marineinspired Oncology

Overview and Status Update

Impact of Collaborative Robots at The Genomics Institute of the Novartis Research Foundation (GNF) Dan Sipes Novartis Foundation

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing

The Right Molecules. Designed. Delivered.

Protein research and bioinformatics

Rare diseases in the 7th EU Framework Programme for Research and Technological Development

NEW MOLECULAR IMAGING LABS TO UNDERPIN SINGAPORE S BIOMEDICAL RESEARCH EFFORTS

WHAT IS BIOCHEMISTRY

Northwestern s Shared and Core Facilities

Capabilities & Services

Focus on Health Research

International Conference on Biochemistry, Genetics & Molecular Research Theme: An Evolving Science of Life

Webinar IMI2 Call 14 Opportunities for SMEs

From Bench to Bedside. Russ H. Read June 23, 2014

The main goal of the strategic partnership is the development of innovative, all-natural cosmetic active ingredients and aroma molecules.

MRC-NIHR National Phenome Centre

Translational Research

Biosimilars: The Impact on Academic Pharmacy

4 th ESPT SUMMER SCHOOL

VIB: From Science to Value

Translational Medicine From Discovery to Health

Genomics Research Center: Current Status & Future Development

Basic Information. I.1 If your company performs biotechnology research and development, uses a. The Categories of Biotechnology Applications.

Genomics and Proteomics *

About ICarbonX. Learn more:

Quality & Safety GLP. 44 q&more 02/14

NIH-RAID: A ROADMAP Program

Micar Innovation. Drug Discovery Factory for novel drug molecules

Focus Area DynAge 7th Call for Applications

The National Institutes of Health ICs: mission and funding strategies

University of Eastern Finland (UEF) Main Research Lines

Biomedical Sciences Graduate Program

Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA )

Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development

Principles of translational medicine: imaging, biomarker imaging, theranostics

Introducing the Department of Life Sciences

Bridging the Gap Between Basic and Clinical Research. Julio E. Celis Danish Cancer Society

BIOTECHNOLOGY & LIFE SCIENCES

SINGAPORE RESEARCHERS DEVELOP WORLD S FIRST HIGH- THROUGHPUT IMAGING PLATFORM FOR PREDICTING KIDNEY TOXICITY

DENMARK A COUNTRY OF QUALITY OVER QUANTITY

Successful and Faster Drug Development through Data Mining Dirk Belmans, Ph.D. SAS Belgium

FROM SCIENCE TO INNOVATION

Week 1: Discovery Biology Basic knowledge and tools used in Research and Development

Computational Biology

Conference Exhibitors

building better science

Master of Science in Translational Biotechnology

List of contributors List of abbreviations. 1 The business of healthcare innovation in the Wharton School curriculum 1

Recent years have witnessed an expansion in the disciplines encompassing drug

Bioscientists Do you have the Bayer Spirit?

SPEED UP YOUR TIME TO MARKET

ATIP Avenir Program 2019 Young group leader. Guide for applicants

Transcription:

Welcome

Berlin-Buch health location in the northeast of Berlin Hennigsdorf Buch D HMI Prenzlauer Berg Mitte TU HU Charlottenburg Dahlem Adlershof FU WISTA Golm Potsdam Luckenwalde

Berlin-Buch health and resaerch for about 100 years Since 1914: Europe s largest hospital city composed of 5 large sites with more than 5.000 bedsides Centre of medical maximum and special care Since 1930: Centre of medical sciences Since 1945: Centre of training and education in medical professions and of research in cardiovascular, cancer, and cell biology

Heath Location Berlin-Buch International recognized basic research in life sciences at MDC and FMP, translational research in Charité and BIH Center of clinical of maximum care and specialized medical care One of the largest Biotechnology Park in Europe with currently 54 Biotech companies

Berlin-Buch facts and figures Research Institutions MDC, FMP, Charité Institutional funding 100 Mio. Third party funding 32 Mio. Personnel 2.000 thereof scientists 1.450 Research Institutions MDC, FMP, Charité Companies 54 Revenue per year 140 Mio. Personnel 800

Translational Research Charité University Medicine Berlin ECRC, Experimental and Clinical Research Center BIH, Berlin Institute of Health Biotech Park with 54 companies Basic Research MDC, Max Delbrück Center for Molecular Medicine FMP, Leibniz Institute for Molecular Pharmacology

Cardiovascular diseases Cancer resaerch Diseases of the nervous system Systems biology (BIMSB) Translation Technology Platforms

Leibniz-Institute for Molecular Pharmakology Molecular Physioloy und Cell Biology Structural Biology Chemical Biology Focus of Research : Identification, characterization, and manipulation of biological targets for pharmacological interference Development of novel chemical tools, probes and experimental strategies that address biological function Integration of structural biology, genetic, biochemical, chemical, and bioimaging approaches Method development (e.g. NMR, MRI, chemical synthesis) (Patho-) Mechanisms Small Molecule Screening Preclinical Phase Clinical Phase Approval / Marketing

EXPERIMENTAL AND CLINICAL RESEARCH CENTER (ECRC) Joint institution of Charité and MDC Budget: 10 Mio. per year Protected time for clinicians Research groups and project groups Funding of collaborative projects of basic scientists and clinicians Infrastructure for research with patients and probands Clinical research unit 11 Interdisciplinary university ambulances GMP-Facility for cell based immune therapy Ultra high field MRI Epidemiology (German National Cohort)

National center for biomedical translational research Charité - largest university hospital in Europe Max Delbruck Center ranks #14 in the top 20 list of research institutes for molecular biology and genetics (53.91 citations per paper) Biomedical researchers, clinical researchers, and clinical practitioners in joint locations Source: MPIKG $ 325 Mio. funding until 2018 90% by BMBF $ 120 Mio. in BIH research $ 100 Mio. in research infrastructure www.charite.de www.mdc-berlin.de www.bihealth.org Source: Berliner Zeitung - 2015/01/18 Source: 2010 Thompson Reuters: http://scientific.thomsonreuters.com/products/esi Page 11 be Innovative! be International! be Berlin!

Scientific Excellence 21 ERC awardees 4 Leibniz awardees 6 awardees of the German Cancer Prize 12 EMBO members 7 Leopoldina members Humboldt-Ranking 2009 2013: rank 2 in life sciences

SCIENTIFIC TECHNOLOGY PLATTFORMS Imaging Light microskopy MRT EM NMR Omics Genomics Proteomics Metabolomics Animal models Generierung von Tiermodellen (Maus, Ratte) Pathophysiology & Phenotyping Etc. FACS, Interactomics, Microarrays, Protein Sample Production ipscs Bioinformatics Chemical Biology & Screening Seite 13

LEIBNIZ-INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE Joint MDC & FMP Chemical Biology Unit From Target-to-Clinic The translational drug discovery value chain Target Identification &Validation HTS Screening Hit to Lead Identification Candidate Identification Pre-clinical Phase I / IIa Phase IIb / III Registration & Approval Drug Design Assay Dev. Compoundmanagement Processautomation Screening Medicinal Chemistry Database/ IT CC MC SU SU SU MC SU/CC CC: Computational Chemistry SU: Screening Unit MC: Medicinal Chemistry

BiotechPark Berlin-Buch 31.000 m² branch specific laboratory und office space 5 state of the art buildings with separated units currently 54 companies with about 800 employees

Dynamic Growth of the BiotechPark 1000 900 800 700 600 500 400 300 200 100 No. of Companies No. of Emploees 0 1991 1996 2001 2011 2016

54 Biotech companies Medical Technology Eckert & Ziegler AG Other Patent Attorneys Drug Development Silence, MerLion, Glycotope,Evotec Drug Discovery Service KfBB, epo Service Imagenes, emp, Biosyntan Molecular Diagnostic Invitek; BioTeZ, Congen, Human Drug Delivery ALRISE, Celares

Hidden Champions of the BiotechPark One of the largest provider of isotope technique compounds for radiotherapy Revenue: 126 Mio Euro in 2013 Employees: 560 Spin off company from MDC developing specific antibodies against cancer Employees: 130 Spin off company from MDC leading in preclinical cancer research in Germany, Service provider for the development of novel antitumor substances or treatment concepts Employees: 43

Cell Isolation Pre- ScreenedCells Cell Assays RNA Preparation

Berlin Cures GmbH, Berlin, Germany Pipeline: BC007 - A 15mer Aptamer that neutralizes Autoantibodies against GPCR Receptors Preclinical studies concluded - Phase 1 study immanent First indication: Autoantibody-pos. Congestive Heart Failure US and EP patent granted Other indications to follow www.berlincures.de info@berlincures.de

Extension of the BiotechPark Requirements: lab and office space, functional space, cold rooms, as well storage space special space: clean rooms, special experimental equipment etc. Flexibel modular units Rental space: ca. 10.000 m 2

Extension Area of the BiotechPark

Gläsernes Labor Life Science Learning Lab Place of extracurricular learning with five laboratories und more than 20 different experiments for more than 15.000 pupils per year Lab courses for pupils in chemistry, genetics, cell biology, neurobiology, ecology Learning programs and programs for very talented pupils in natural sciences from kindergarten to high school graduation Certified specific advanced training for Job & further career in Life Sciences http://www.bbb-berlin.de/en/glaesernes_labor.html

Many thanks for your attention. Dr. Christina Quensel Robert-Rössle-Straße 10 D-13125 Berlin Phone: +49 (0)30 9489 2511 Fax: +49 (0)30 9489 3812 Mail: Web: cquensel@bbb-berlin.de www.bbb-berlin.de